SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins rally above the $0.60 level and breakout-focused trading are drawing attention, with traders pointing to Eightcos disclosed large WLD holdings and the tokens proof-of-humanity pitch amid growing AI-agent concerns. Sentiment is largely bullish, though some traders warn that the move is volatile and question whether it can hold.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is drawing attention amid a sharp pullback in obesity-biotech stocks, despite positive clinical updates for its oral obesity-drug pipeline. Traders are split: skeptics cite questions about efficacy durability, side effects and the long Phase 3 timeline, while bullish investors view the pipeline as undervalued and speculate about a potential pharma partnership or buyout.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Discussion centers on new real-world comparisons of DefenCath with ClearGuard and what they mean for adoption and reimbursement. Bulls point to infection-reduction evidence and expanded dialysis-provider use, while skeptics cite comparable outcomes in one study and uncertainty around post-TDAPA and Medicare Advantage coverage.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compounds institutional push and anticipated V4 upgrade are recurring catalysts, with bullish traders also pointing to its capped token supply and a possible DeFi or altcoin revival. Others remain skeptical, citing COMPs lagging price action and competition from rival lending protocols.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Traders are focused on Uniswaps Robinhood integration and tokenized-asset activity, alongside the fee-funded UNI buyback-and-burn mechanism that they see as improving token value capture. Many are bullish on the added usage and reduced supply, while others question whether the developments are reflected in the price and point to sharp volatility and pullbacks.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions strong quarterly results and raised outlook, attributed to demand for AI infrastructure and memory solutions, are driving attention and a sharp rally. Bulls see room for continued momentum, while skeptics warn the stock is extended and debate whether the gains are sustainable.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is under pressure amid reports that OpenAIs latest Ultrafast mode uses Nvidia GPUs rather than Cerebras hardware, alongside staged IPO share unlocks and insider selling. Bulls cite Sam Altmans reaffirmation of a close partnership and argue capacity constraintsnot lost demandexplain the shift, while traders debate whether the selling overhang will persist.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is drawing attention for choppy consolidation below a widely watched resistance area after a volatile rally and pullback. Traders are split between expecting a breakout and seeing continued weakness, with many watching whether support holds and noting the coin has lagged broader crypto moves.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis is drawing attention after its Phase 2b LUMUS lupus trial missed the overall study endpoints, triggering a steep selloff. Traders are divided over whether the decline is excessive: some see a remaining lupus signal in the IFNGS-high subgroup and point to the intact psoriasis program, while others remain concerned about the setback and financing needs.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing attention as traders react to sharp, volatile moves in Tesla and look for a rebound, with some buying dips or trading for upside while others take profits or warn about reversals and leverage decay. Cybercab and robotaxi developments add to the bullish speculation, but the conversation is largely focused on short-term Tesla momentum rather than a single confirmed catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy

Minerva Neurosciences (NERV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Minerva Neurosciences (NERV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Minerva Neurosciences (NASDAQ:NERV) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Minerva Neurosciences (NASDAQ:NERV - Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, missing...

Minerva Neurosciences, Inc (NASDAQ:NERV) Short Interest Update

Minerva Neurosciences, Inc (NASDAQ:NERV - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totaling...

Minerva Neurosciences (NASDAQ:NERV) Now Covered by Citizens Jmp

Citizens Jmp began coverage on Minerva Neurosciences in a report on Wednesday. They set an "outperform" rating and a $14.00 target price for the company...

Minerva Neurosciences, Inc (NASDAQ:NERV) Sees Significant Growth in Short Interest

Minerva Neurosciences, Inc (NASDAQ:NERV - Get Free Report) was the target of a large increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,020,925...

Minerva Neurosciences (NASDAQ:NERV) Shares Cross Below Fifty Day Moving Average - Should You Sell?

Minerva Neurosciences (NASDAQ:NERV) Stock Passes Below Fifty Day Moving Average - Here's What Happened...

Short Interest in Minerva Neurosciences, Inc (NASDAQ:NERV) Grows By 27.8%

Minerva Neurosciences, Inc (NASDAQ:NERV - Get Free Report) saw a significant growth in short interest in March. As of March 13th, there was short interest totaling 559,530 shares, a growth of 27.8...

Minerva Neurosciences Touts Roluperidone Data, FDA-Aligned Trial Plan for Schizophrenia Symptoms

Minerva Neurosciences (NASDAQ:NERV) provided an update on its development program for roluperidone, which the company described as a potential first treatment option aimed at the negative symptoms of...

HC Wainwright Has Bullish Forecast for NERV Q1 Earnings

Minerva Neurosciences, Inc (NASDAQ:NERV - Free Report) - Equities research analysts at HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for shares of Minerva Neurosciences in...

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst

Equity

Bullish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

NERV Minerva Neurosciences Inc

Fundamentals

Latest NERV News